Inhalers - Medical Devices Pipeline Assessment, 2018

  • ID: 4580441
  • Report
  • 311 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Bayer AG
  • GlaxoSmithKline Plc
  • Nektar Therapeutics
  • Pharmaxis Ltd
  • United Therapeutics Corp
  • MORE
Inhalers - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Inhalers - Medical Devices Pipeline Assessment, 2018" provides an overview of Inhalers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inhalers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Inhalers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Bayer AG
  • GlaxoSmithKline Plc
  • Nektar Therapeutics
  • Pharmaxis Ltd
  • United Therapeutics Corp
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Inhalers Overview

3 Products under Development
3.1 Inhalers - Pipeline Products by Stage of Development
3.2 Inhalers - Pipeline Products by Segment
3.3 Inhalers - Pipeline Products by Territory
3.4 Inhalers - Pipeline Products by Regulatory Path
3.5 Inhalers - Pipeline Products by Estimated Approval Date
3.6 Inhalers - Ongoing Clinical Trials

4 Inhalers - Pipeline Products under Development by Companies
4.1 Inhalers Companies - Pipeline Products by Stage of Development
4.2 Inhalers - Pipeline Products by Stage of Development

5 Inhalers Companies and Product Overview
5.1 Acorda Therapeutics Inc Company Overview
5.2 Adamis Pharmaceuticals Corp Company Overview
5.3 Advent Pharmaceuticals Pty Ltd Company Overview
5.4 Aespira Ltd. Company Overview
5.5 AKELA Pharma Inc. (Inactive) Company Overview
5.6 Alexza Pharmaceuticals Inc Company Overview
5.7 Aradigm Corp Company Overview
5.8 AstraZeneca Plc Company Overview
5.9 Bayer AG Company Overview
5.10 Bellerophon Therapeutics Inc Company Overview
5.11 Bespak Europe Ltd Company Overview
5.12 Boehringer Ingelheim GmbH Company Overview
5.13 Circassia Pharmaceuticals Plc Company Overview
5.14 Drexel University Company Overview
5.15 FocusStart LLC Company Overview
5.16 GlaxoSmithKline Plc Company Overview
5.17 MannKind Corp Company Overview
5.18 Medihale Ltd (Inactive) Company Overview
5.19 Monash University Company Overview
5.20 Nanotherapeutics Inc (Inactive) Company Overview
5.21 Nektar Therapeutics Company Overview
5.22 Nicoventures Trading Ltd Company Overview
5.23 North Carolina State University Company Overview
5.24 Novartis AG Company Overview
5.25 OPKO Health Inc Company Overview
5.26 Perrigo Company Plc Company Overview
5.27 Pharmaxis Ltd Company Overview
5.28 Pneuma Respiratory Inc Company Overview
5.29 Resolve Digital Health Inc Company Overview
5.30 Respira Therapeutics Inc Company Overview
5.31 Sandoz International GmbH Company Overview
5.32 Sheffield Hallam University Company Overview
5.33 Sun Pharma Advanced Research Company Ltd Company Overview
5.34 Tetra Bio-Pharma Inc Company Overview
5.35 Teva Pharmaceutical Industries Ltd Company Overview
5.36 United Therapeutics Corp Company Overview
5.37 University of Kansas Company Overview
5.38 University of Texas Medical Branch at Galveston Company Overview
5.39 Uscom Ltd. Company Overview
5.40 Vectura Group Plc Company Overview
5.41 Verona Pharma Plc Company Overview
5.42 Virginia Commonwealth University Company Overview

6 Inhalers- Recent Developments
6.1 Jun 07, 2018: MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase
6.2 Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director
6.3 May 24, 2018: Adherium Announces Appointment of David Allinson as Chief Financial Officer
6.4 May 21, 2018: 3M forms sustainability and product stewardship organization
6.5 May 17, 2018: New England Journal of Medicine publishes two trials for Symbicort as an anti-inflammatory reliever therapy as needed in mild asthma
6.6 May 16, 2018: Novartis announces changes to the Executive Committee
6.7 May 16, 2018: At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth
6.8 May 14, 2018: Medical Developments International: Trading Update
6.9 May 10, 2018: Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
6.10 May 10, 2018: Nektar Therapeutics Reports Financial Results for the First Quarter of 2018
6.11 May 10, 2018: Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results
6.12 May 10, 2018: Novartis India reconstitutes Board appoints Milan Paleja as Vice Chairman Managing Director
6.13 May 09, 2018: 3M Announces New Leadership Appointment
6.14 May 09, 2018: MannKind Reports 2018 First Quarter Financial Results
6.15 May 09, 2018: Simon Dingemans, Chief Financial Officer, to retire from GSK
6.16 May 09, 2018: Savara Reports First Quarter 2018 Financial Results and Provides Business Update
6.17 May 08, 2018: OPKO Health Announces First Quarter 2018 Financial Results
6.18 May 03, 2018: Teva Reports First Quarter 2018 Financial Results
6.19 May 02, 2018: Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 6% in local currencies in the first three months of 2018
6.20 May 01, 2018: OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
6.21 Apr 30, 2018: Adherium: Appendix 4C - Quarterly cash flow report to March 31 2018
6.22 Apr 26, 2018: Consort Medical: Director Declaration
6.23 Apr 25, 2018: Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
6.24 Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year
6.25 Apr 24, 2018: Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD
6.26 Apr 20, 2018: Vectura Announces Senior Management Change
6.27 Apr 20, 2018: Vectura Group: Directorate Change - Chief Financial Officer
6.28 Apr 19, 2018: Boehringer Ingelheim and HealthPrize Expand Successful Digital Patient Support Program
6.29 Apr 19, 2018: Novartis delivered a strong first quarter and acted to become a more focused medicines company
6.30 Apr 19, 2018: Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer
6.31 Apr 18, 2018: Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD
6.32 Apr 18, 2018: GlaxoSmithKline Names Kevin Sin as new Senior Vice President and Head of Worldwide Business Development for Research & Development
6.33 Apr 16, 2018: Pneuma Respiratory Appoints Rich Gimigliano As Chief Financial Officer
6.34 Apr 16, 2018: Cipla: US FDA conducted a routine current Good Manufacturing Practices (cGMP) audit at its Indore formulations facility
6.35 Apr 09, 2018: Pneuma Respiratory Appoints Dr. Steven Kesten as President and Chief Medical Officer
6.36 Apr 04, 2018: Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Inhalers - Pipeline Products by Stage of Development
Table 2: Inhalers - Pipeline Products by Segment
Table 3: Inhalers - Pipeline Products by Territory
Table 4: Inhalers - Pipeline Products by Regulatory Path
Table 5: Inhalers - Pipeline Products by Estimated Approval Date
Table 6: Inhalers - Ongoing Clinical Trials
Table 7: Inhalers Companies - Pipeline Products by Stage of Development
Table 8: Inhalers - Pipeline Products by Stage of Development
Table 9: Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: CVT-427 Drug Delivery Device - Product Status
Table 11: CVT-427 Drug Delivery Device - Product Description
Table 12: INBRIJA - Product Status
Table 13: INBRIJA - Product Description
Table 14: PLUMIAZ Nasal Spray Device - Product Status
Table 15: PLUMIAZ Nasal Spray Device - Product Description
Table 16: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Taper DPI - Product Status
Table 18: Taper DPI - Product Description
Table 19: Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: g60 Dry Powder Inhaler - Product Status
Table 21: g60 Dry Powder Inhaler - Product Description
Table 22: Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 23: resQhaler - Product Status
Table 24: resQhaler - Product Description
Table 25: AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Fentanyl TAIFUN Inhaler - Product Status
Table 27: Fentanyl TAIFUN Inhaler - Product Description
Table 28: Alexza Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Staccato System - Disposable Single Dose - Product Status
Table 30: Staccato System - Disposable Single Dose - Product Description
Table 31: Staccato System - Multiple Dose - Product Status
Table 32: Staccato System - Multiple Dose - Product Description
Table 33: Aradigm Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Aerx Pure Nicotine Inhaler - Product Status
Table 35: Aerx Pure Nicotine Inhaler - Product Description
Table 36: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Duaklir Genuair Metered Dose Inhaler - Product Status
Table 38: Duaklir Genuair Metered Dose Inhaler - Product Description
Table 39: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Ciprofloxacin Dry Powder Inhaler - Product Status
Table 41: Ciprofloxacin Dry Powder Inhaler - Product Description
Table 42: Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Mark2 Device - Product Status
Table 44: Mark2 Device - Product Description
Table 45: Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 46: DEV610 DPI - Product Status
Table 47: DEV610 DPI - Product Description
Table 48: Boehringer Ingelheim GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Next Generation Respimat Inhaler - Product Status
Table 50: Next Generation Respimat Inhaler - Product Description
Table 51: Circassia Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Tiotropium bromide DPI - Product Status
Table 53: Tiotropium bromide DPI - Product Description
Table 54: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 55: BREATHE Inhaler - Product Status
Table 56: BREATHE Inhaler - Product Description
Table 57: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Smart Inhaler - Product Status
Table 59: Smart Inhaler - Product Description
Table 60: GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Gemini Multi-Dose Combination Inhaler - Product Status
Table 62: Gemini Multi-Dose Combination Inhaler - Product Description
Table 63: MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Dreamboat - Product Status
Table 65: Dreamboat - Product Description
Table 66: Treprostinil Technosphere - Product Status
Table 67: Treprostinil Technosphere - Product Description
Table 68: Medihale Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Toucan Multi-Dose Inhaler - Product Status
Table 70: Toucan Multi-Dose Inhaler - Product Description
Table 71: Monash University Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Aerosol Delivery System - Product Status
Table 73: Aerosol Delivery System - Product Description
Table 74: Nanotherapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 75: GelVac Intranasal Powder Vaccine Delivery System - Product Status
Table 76: GelVac Intranasal Powder Vaccine Delivery System - Product Description
Table 77: NanoGENT - Product Status
Table 78: NanoGENT - Product Description
Table 79: Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Nektar Dry Powder Inhaler - Amikacin - Product Status
Table 81: Nektar Dry Powder Inhaler - Amikacin - Product Description
Table 82: Nicoventures Trading Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Nicadex Electronic Inhaler - Product Status
Table 84: Nicadex Electronic Inhaler - Product Description
Table 85: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Smart Inhaler System - Product Status
Table 87: Smart Inhaler System - Product Description
Table 88: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Next Generation Breezhaler Inhaler - Product Status
Table 90: Next Generation Breezhaler Inhaler - Product Description
Table 91: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Inspiromatic - Product Status
Table 93: Inspiromatic - Product Description
Table 94: Perrigo Company Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 95: ProAir Inhalation Aerosol - Product Status
Table 96: ProAir Inhalation Aerosol - Product Description
Table 97: Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Orbital Dry Powder Inhaler - Product Status
Table 99: Orbital Dry Powder Inhaler - Product Description
Table 100: Pneuma Respiratory Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 101: PNEUMAHALER - Product Status
Table 102: PNEUMAHALER - Product Description
Table 103: Resolve Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 104: Breeze Smart Inhaler - Product Status
Table 105: Breeze Smart Inhaler - Product Description
Table 106: Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 107: RT234 AOS DPI - Product Status
Table 108: RT234 AOS DPI - Product Description
Table 109: Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Solis Multi-Dose Dry Powder Inhaler - Product Status

List of Figures
Figure 1: Inhalers - Pipeline Products by Stage of Development
Figure 2: Inhalers - Pipeline Products by Segment
Figure 3: Inhalers - Pipeline Products by Territory
Figure 4: Inhalers - Pipeline Products by Regulatory Path
Figure 5: Inhalers - Pipeline Products by Estimated Approval Date
Figure 6: Inhalers - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Acorda Therapeutics Inc
  • Adamis Pharmaceuticals Corp
  • Advent Pharmaceuticals Pty Ltd
  • Aespira Ltd.
  • AKELA Pharma Inc.
  • Alexza Pharmaceuticals Inc
  • Aradigm Corp
  • AstraZeneca Plc
  • Bayer AG
  • Bellerophon Therapeutics Inc
  • Bespak Europe Ltd
  • Boehringer Ingelheim GmbH
  • Circassia Pharmaceuticals Plc
  • Drexel University
  • FocusStart LLC
  • GlaxoSmithKline Plc
  • MannKind Corp
  • Medihale Ltd
  • Monash University
  • Nanotherapeutics Inc
  • Nektar Therapeutics
  • Nicoventures Trading Ltd
  • North Carolina State University
  • Novartis AG
  • OPKO Health Inc
  • Perrigo Company Plc
  • Pharmaxis Ltd
  • Pneuma Respiratory Inc
  • Resolve Digital Health Inc
  • Respira Therapeutics Inc
  • Sandoz International GmbH
  • Sheffield Hallam University
  • Sun Pharma Advanced Research Company Ltd
  • Tetra Bio-Pharma Inc
  • Teva Pharmaceutical Industries Ltd
  • United Therapeutics Corp
  • University of Kansas
  • University of Texas Medical Branch at Galveston
  • Uscom Ltd.
  • Vectura Group Plc
  • Verona Pharma Plc
  • Virginia Commonwealth University
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll